Merck KGaA Backs Outlook After Drop in Sales, Earnings
Wall Street Journal
Merck KGaA confirmed and detailed its guidance for 2024 after it reported lower sales and earnings for the first quarter, hit by inventory reductions at its life-science segment.
https://www.wsj.com/articles/merck-kgaa-confirms-outlook-after-drop-in-sales-earnings-33094b51